dual glp 1 and gip receptor agonist examples This review summarizes how GLP-1 GIP/GLP-1 agonists act at the cellular level and their therapeutic applications in metabolic diseases like type 2 diabetes and obesity, highlighting advances in incretin-based The dual agonist action of

Although not a panacea, lower doses can still activate critical physiological pathways across a variety of populations, which helps explain why GLP-1 microdosing is gaining serious traction

Lo J, Mehta K, Dhillon A, et al

Switching Between Medications Many patients consider switching from Trulicity to Ozempic, and this is commonly done

Another 2025 article demonstrated that GLP-1 agonists were associated with development of NAION among Medicare enrollees

Weight-loss drugs like GLP-1 agonists could play an important role in improving the health of the nation, added study co-author, Professor Clare Llewellyn (UCL Institute of Epidemiology & Health Care)